-
90081por Lopatina, Tatiana, Grange, Cristina, Cavallari, Claudia, Navarro-Tableros, Victor, Lombardo, Giusy, Rosso, Arturo, Cedrino, Massimo, Pomatto, Margherita Alba Carlotta, Koni, Malvina, Veneziano, Francesca, Castellano, Isabella, Camussi, Giovanni, Brizzi, Maria Felice“…In vivo, anti-IL-3R-EV treatment induced vessel regression in established tumors formed of MDA-MB-231 cells, decreased Vimentin, β-catenin, and TWIST1 expression, almost abolished liver and lung metastases from primary tumors, and reduced lung metastasis generated via the intravenous injection of MDA-MB-231 cells. nEVs depleted of miR-24-3p (antago-miR-24-3p-EVs) were effective as anti-IL-3R-EVs in downregulating TWIST1 and reducing metastatic lesions in vivo. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90082por Siu, Lillian, Brody, Joshua, Gupta, Shilpa, Marabelle, Aurélien, Jimeno, Antonio, Munster, Pamela, Grilley-Olson, Juneko, Rook, Alain H, Hollebecque, Antoine, Wong, Rebecca K S, Welsh, James W, Wu, Yuling, Morehouse, Christopher, Hamid, Oday, Walcott, Farzana, Cooper, Zachary A, Kumar, Rakesh, Ferté, Charles, Hong, David S“…The maximum tolerated dose of MEDI9197 monotherapy was 0.037 mg, with dose-limiting toxicity (DLT) of cytokine release syndrome in two patients (one grade 3, one grade 4) and 0.012 mg in combination with durvalumab 1500 mg with DLT of MEDI9197-related hemorrhagic shock in one patient (grade 5) following liver metastasis rupture after two cycles of MEDI9197. Across parts 1 and 3, the most frequent MEDI9197-related adverse events (AEs) of any grade were fever (56%), fatigue (31%), and nausea (21%). …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90083“…The AUC of miR-144-3p and PTEN was >0.8. miR-144-3p and PTEN were related to TNM stage, lymph node metastasis and differentiation degree of TC patients. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90084“…Hazard ratios with 95% confidence intervals of overall survival (OS), cancer-specific survival (CSS), disease-free survival (DFS), recurrence-free survival (RFS), metastasis-free survival (MFS), and progression-free survival (PFS) were extracted from the multivariate analyses and analyzed with fixed or random effects models when applicable. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90085por Quigley, Neil Gerard, Steiger, Katja, Richter, Frauke, Weichert, Wilko, Hoberück, Sebastian, Kotzerke, Jörg, Notni, Johannes“…PURPOSE: As a major activator of transforming growth factor β (TGF-β), the RGD receptor αvβ8-integrin is involved in pathogenic processes related to TGF-β dysregulation, such as tumor growth, invasion, and radiochemoresistance, metastasis and tumor cell stemness, as well as epithelial-mesenchymal transition. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90086“…GSEA analysis showed that several gene sets associated with tumor development and metastasis, including TGF-β signaling, PI3K-AKT-mTOR signaling, and IL6-JAK-STAT3 signaling, were significantly enriched in POLR3G high expression phenotype. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90087por Zheng, Yaxin, Luo, Mao, Lü, Muhan, Zhou, Tiejun, Liu, Fang, Guo, Xiaoni, Zhang, Jian, Kang, Min“…RESULTS: We found that let-7c-5p expression was downregulated in ESCC tissue and cell lines, and its reduced expression was correlated with TNM staging and lymph node metastasis. Next, we found that let-7c-5p can be used to discriminate ESCC patients from normal control subjects by receiver operating characteristic (ROC) curve analysis. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90088por Wong, Gabriel Chun-Hei, Li, Kay Ka-Wai, Wang, Wei-Wei, Liu, Anthony Pak-Yin, Huang, Queenie Junqi, Chan, Aden Ka-Yin, Poon, Manix Fung-Man, Chung, Nellie Yuk-Fei, Wong, Queenie Hoi-Wing, Chen, Hong, Chan, Danny Tat Ming, Liu, Xian-Zhi, Mao, Ying, Zhang, Zhen-Yu, Shi, Zhi-Feng, Ng, Ho-Keung“…Multivariate analysis identified histological type (p = 0.026), metastasis (p = 0.031) and KMT2C mutational status (p = 0.046) as independent prognosticators in our cohort. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90089“…BACKGROUND: Tumour subtype has a significant effect on bone metastasis in breast cancer, but population-based estimates of the prognosis of patients with bone metastases at breast cancer diagnosis are lacking. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90090por Hwang, Ilseon, Kim, Jeong Won, Ylaya, Kris, Chung, Eun Joo, Kitano, Haruhisa, Perry, Candice, Hanaoka, Jun, Fukuoka, Junya, Chung, Joon-Yong, Hewitt, Stephen M.“…BACKGROUND: The tumor microenvironment (TME) is a critical player in tumor progression, metastasis and therapy outcomes. Tumor-associated macrophages (TAMs) are a well-recognized core element of the TME and generally characterized as M2-like macrophages. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90091“…Age > 60, sex, race, AJCC stages, metastasis, and LRT were not significant. However, API vs white showed significant OR of 2.793 (CI: 1.120-6.967). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90092“…RESULTS: Univariable analysis showed that tumor size (P = 0.018 in OS), and P = 0.021 in RFS), tumor stage(P < 0.001 in OS, and P = 0.002 in RFS), nodal metastasis (P < 0.001 in OS, and P < 0.001 in RFS), pathological stage (P < 0.001 in OS, and P < 0.001 in RFS), treatment modality (P = 0.032 in OS, and P = 0.059 in RFS) and PNI (P < 0.001 in OS, and P < 0.001 in RFS), were significant factors of both OS and RFS. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90093por Desa, Danielle E., Strawderman, Robert L., Wu, Wencheng, Hill, Robert L., Smid, Marcel, Martens, J. W. M., Turner, Bradley M., Brown, Edward B.“…The ratio of forward- to backward-scattered SHG photons (F/B) is sensitive to collagen fiber internal structure and has been shown to be an independent prognostic indicator of metastasis-free survival time (MFS). Here we assess the effects of heterogeneity in the tumor matrix on the possible use of F/B as a prognostic tool. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90094por Niu, Qiuling, Dong, Zhijie, Liang, Min, Luo, Yuanwei, Lin, Hai, Lin, Mingzhen, Zhong, Xiu, Yao, Wenxia, Weng, Jinsheng, Zhou, Xinke“…Finally, the mice xenograft and metastasis models were constructed to assess the function of hsa_circ_0001829 in vivo. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90095por Arthur, Lauren E., McMann, Ashley H., Slattery, Lauren N., Fuhrman, George M., Mackey, Aimee M., Rivere, Amy E., Corsetti, Ralph L.“…Background: Traditionally, breast cancer is staged using TNM criteria: tumor size (T), nodal status (N), and metastasis (M). The Oncotype DX assay provides a recurrence score (RS) based on genomics that predicts the likelihood of distant recurrence in estrogen receptor–positive (ER+)/human epidermal growth factor receptor 2–negative (HER2–)/lymph node–negative (LN–) tumors. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90096por Qiu, Jianhui, Zhang, Kenan, Ma, Kaifang, Zhou, Jingcheng, Gong, Yanqing, Cai, Lin, Gong, Kan“…Further genotype-phenotype studies should focus on the prediction of tumor recurrence, progression, and metastasis. The deep molecular mechanism of genotype-phenotype correlation is worth further exploring.…”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90097por Selnæs, Kirsten Margrete, Krüger-Stokke, Brage, Elschot, Mattijs, Johansen, Håkon, Steen, Per Arvid, Langørgen, Sverre, Aksnessæther, Bjørg Yksnøy, Indrebø, Gunnar, Sjøbakk, Torill Anita Eidhammer, Tessem, May-Britt, Moestue, Siver Andreas, Knobel, Heidi, Tandstad, Torgrim, Bertilsson, Helena, Solberg, Arne, Bathen, Tone Frost“…Multiparametric MRI (mpMRI) and PET/MRI were scored on a 3-point scale (1-negative, 2-equivocal, 3-recurrence/metastasis) and detection rates (number of patients with suspicious findings divided by total number of patients) were reported. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90098por Lim, Jihye, Kim, Ha Il, Kim, Eunju, Kim, Jiyoon, An, Jihyun, Chang, Seheon, Kim, Seon-Ok, Lee, Han chu, Lee, Yung Sang, Shim, Ju Hyun“…Prolonged prothrombin time, lower platelet count, presence of extrahepatic metastasis, and Vp4 PVTT were independent risk factors related to high-risk varices in the total set of 206 patients with PVTT (Adjusted odds ratios [95% CIs], 1.662 [1.151–2.401]; 0.985 [0.978–0.993]; 4.240 [1.783–10.084]; and 3.345 [1.457–7.680], respectively; Ps < 0.05). …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90099por Akamatsu, Hiroaki, Toi, Yukihiro, Hayashi, Hidetoshi, Fujimoto, Daichi, Tachihara, Motoko, Furuya, Naoki, Otani, Sakiko, Shimizu, Junichi, Katakami, Nobuyuki, Azuma, Koichi, Miura, Naoko, Nishino, Kazumi, Hara, Satoshi, Teraoka, Shunsuke, Morita, Satoshi, Nakagawa, Kazuhiko, Yamamoto, Nobuyuki“…Among those randomized, the median (range) age was 68 (41-82) years; 33 (41%) were male; 37 (46%) had an Eastern Cooperative Oncology Group performance status of 0; and 21 (26%) had brain metastasis. Although the overall response rate was better with osimertinib plus bevacizumab than osimertinib alone (68% vs 54%), median PFS was not longer with osimertinib plus bevacizumab (9.4 months vs 13.5 months; adjusted hazard ratio, 1.44; 80% CI, 1.00 to 2.08; P = .20). …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90100por Solis-Pazmino, Paola, Salazar-Vega, Jorge, Lincango-Naranjo, Eddy, Garcia, Cristhian, Koupermann, Gabriela Jaramillo, Ortiz-Prado, Esteban, Ledesma, Tannya, Rojas, Tatiana, Alvarado-Mafla, Benjamin, Carcamo, Cesar, Ponce, Oscar J., Brito, Juan P.“…Thyroid cancer histology reported that 93.3% had papillary thyroid cancer (PTC), 2.7% follicular, 1.5% Hurtle cells, 1.6% medullary, 0.7% poor differentiated, and 0.2% anaplastic carcinoma. The mean MACIS (metastasis, age, completeness, invasion, and size) score was 4.95 (CI 4.15–5.95) with 76.2% of the thyroid cancer patients having MACIS score less than or equal to 6. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto